Review of the efficacy and tolerability of the diclofenac epolamine topical patch 1.3% in patients with acute pain due to soft tissue injuries

Clinical Therapeutics

Volumn 32, Issue 6, 2010, Pages 1001-1014

  Kuehl, Kerry S ^a  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

Contusions; Diclofenac epolamine topical patch; NSAIDs; Soft tissue injury; Sports injury; Sprains; Strains; Topical analgesics

Indexed keywords

DICLOFENAC DERIVATIVE; DICLOFENAC DIETHYLAMMONIUM; DICLOFENAC EPOLAMINE; NONSTEROID ANTIINFLAMMATORY AGENT; UNCLASSIFIED DRUG;

APPLICATION SITE DERMATITIS; APPLICATION SITE PRURITUS; APPLICATION SITE RASH; APPLICATION SITE REACTION; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CLINICAL TRIAL; CONTUSION; DIGESTIVE SYSTEM PERFORATION; DRUG EFFICACY; DRUG HYPERSENSITIVITY; DRUG TOLERABILITY; DRUG WITHDRAWAL; ERYTHEMA; GEL; HEADACHE; HUMAN; MUSCLE CRAMP; NAUSEA; NEPHROTOXICITY; PAIN; PREVALENCE; PRURITUS; RASH; REVIEW; SIDE EFFECT; SKIN TOXICITY; SOFT TISSUE INJURY; SPRAIN; TOOTH PAIN; TREATMENT OUTCOME; UPPER GASTROINTESTINAL BLEEDING; VISUAL ANALOG SCALE;

ACUTE DISEASE; ADMINISTRATION, CUTANEOUS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CLINICAL TRIALS AS TOPIC; DICLOFENAC; DRUG DELIVERY SYSTEMS; HUMANS; PAIN; PAIN MEASUREMENT; SOFT TISSUE INJURIES; TIME FACTORS;

EID: 77954632418     PISSN: 01492918     EISSN: 1879114X     Source Type: Journal    
DOI: 10.1016/j.clinthera.2010.06.001     Document Type: Review

References (47)

1. Chen LH, Warner M, Fingerhut L, Makuc D Injury episodes and circumstances: National Health Interview Survey, 1997-2007. Vital Health Stat 2009, 10:1-55.
2. Garrett WE Muscle strain injuries: Clinical and basic aspects. Med Sci Sports Exerc. 1990, 22:436-443.
3. Liu SH, Nguyen TM Ankle sprains and other soft tissue injuries. Curr Opin Rheumatol. 1999, 11:132-137.
4. Almekinders LC Anti-inflammatory treatment of muscular injuries in sport. An update of recent studies. Sports Med. 1999, 28:383-388.
5. Slatyer MA, Hensley MJ, Lopert R A randomized controlled trial of piroxicam in the management of acute ankle sprain in Australian Regular Army recruits. The Kapooka Ankle Sprain Study. Am J Sports Med. 1997, 25:544-553.
6. Petrella R, Ekman EF, Schuller R, Fort JG Efficacy of cele-coxib, a COX-2-specific inhibitor, and naproxen in the management of acute ankle sprain: Results of a doubleblind, randomized controlled trial. Clin J Sport Med. 2004, 14:225-231.
7. Curtis JR, Olivieri J, Allison JJ, et al. A group randomized trial to improve safe use of nonsteroidal anti-inflammatory drugs. Am J Manag Care. 2005, 11:537-543.
8. Latimer N, Lord J, Grant RL, et al. Cost effectiveness of COX 2 selective inhibitors and traditional NSAIDs alone or in combination with a proton pump inhibitor for people with osteoarthritis. BMJ. 2009, 339:b2538. National Institute for Health and Clinical Excellence Osteoarthritis Guideline Development Group.
9. Moore RA, Derry S, Phillips CJ, McQuay HJ Nonsteroidal anti-inflammatory drugs (NSAIDs), cyclooxygenase-2 selective inhibitors (coxibs) and gastrointestinal harm: Review of clinical trials and clinical practice. BMC Musculoskelet Disord. 2006, 7:79.
10. Brater DC Effects of nonsteroidal anti-inflammatory drugs on renal function: Focus on cyclooxygenase-2-selective inhibition. Am J Med. 1999, 107:65S-70S. discussion.
11. Brater DC Effects of nonsteroidal anti-inflammatory drugs on renal function: Focus on cyclooxygenase-2-selective inhibition. Am J Med. 1999, 107:70S-71S.
12. Mukherjee D, Nissen SE, Topol EJ Risk of cardiovascular events associated with selective COX-2 inhibitors. JAMA 2001, 286:954-959.
13. Galer BS, Rowbotham M, Perander J, et al. Topical diclofenac patch relieves minor sports injury pain: Results of a multicenter controlled clinical trial. J Pain Symptom Manage. 2000, 19:287-294.
14. Stanos SP Topical agents for the management of muscu-loskeletal pain. J Pain Symptom Manage. 2007, 33:342-355.
15. Moore RA, Tramèr MR, Carroll D, et al. Quantitative systematic review of topically applied non-steroidal antiinflammatory drugs [published correction appears in BMJ. 1998;316:1059]. BMJ 1998, 316:333-338.
16. Akermark C, Forsskåhl B Topical indomethacin in overuse injuries in athletes. A randomized double-blind study comparing Elmetacin with oral indomethacin and placebo. Int J Sports Med. 1990, 11:393-396.
17. Browning RC, Johson K Reducing the dose of oral NSAIDs by use of Feldene Gel: An open study in elderly patients with osteoarthritis. Adv Ther. 1994, 11:198-207.
18. Golden EL A double-blind comparison of orally ingested aspirin and a topically applied salicylate cream in the relief of rheumatic pain. Curr Ther Res Clin Exp 1978, 24:524-529.
19. Hosie GA The topical NSAID felbinac versus oral ibuprofen: A comparison of efficacy in the treatment of acute lower back injury. Br J Clin Res. 1993, 4:5-17.
20. Vanderstraeten G, Schuermans P Study on the effect of etofenamate 10% cream in comparison with an oral NSAID in strains and sprains due to sports injuries. Acta Belg Med Phys. 1990, 13:139-141.
21. Towheed TE Pennsaid therapy for osteoarthritis of the knee: A systematic review and metaanalysis of randomized controlled trials. J Rheumatol. 2006, 33:567-573.
22. Tugwell PS, Wells GA, Shainhouse JZ Equivalence study of a topical diclofenac solution (Pennsaid) compared with oral diclofenac in symptomatic treatment of osteoarthritis of the knee: A randomized controlled trial. J Rheumatol. 2004, 31:2002-2012.
23. Zacher J, Altman R, Bellamy N, et al. Topical diclofenac and its role in pain and inflammation: An evidence-based review. Curr Med Res Opin. 2008, 24:925-950.
24. Evans JM, McMahon AD, McGilchrist MM, et al. Topical non-steroidal anti-inflammatory drugs and admission to hospital for upper gastrointestinal bleeding and perforation: A record linkage case-control study. BMJ. 1995, 311:22-26.
25. Flector Patch (diclofenac epolamine topical patch) [package insert], Accessed April 30 2010. http://www.kingpharm.com/products/product_document.cfm?brand_name=Flector&product_specific_name=Patch&document_type_code=PI.
26. Kantor TG Use of diclofenac in analgesia. Am J Med. 1986, 80:64-69.
27. Rovati S, Garavani A Research and development of a pharmaceutical technique allowing for improvement in clinical efficacy and simplicity of use of known drugs. Tribuna Medi Ticinese. 2000, 61:204-207.
28. Assandri A, Canali S, Giachetti C Local tolerability and pharmaco-kinetic profile of a new transdermal delivery system, diclofenac hydroxy-ethylpyrrolidine plaster. Drugs Exp Clin Res. 1993, 19:89-95.
29. Fini A, Fazio G, Gonzalez-Rodriguez M, et al. Formation of ion-pairs in aqueous solutions of diclofenac salts. Int J Pharm. 1999, 187:163-173.
30. Fini A, Fazio G, Rapaport I Diclofenac/N-(2-hydroxyethyl)pyrrolidine: A new salt for an old drug. Drugs Exp Clin Res. 1993, 19:81-88.
31. Rainsford KD, Kean WF, Ehrlich GE Review of the pharmaceutical properties and clinical effects of the topical NSAID formulation, diclofenac epolamine. Curr Med Res Opin. 2008, 24:2967-2992.
32. Fini A, Fazio G, Orienti I, et al. Chemical properties-dissolution relationship. IV. Behaviour in solution of the diclofenac/N-(2-hydroxyethyl) pyrrolidine salt (DHEP). Pharm Acta Helv. 1991, 66:201-203.
33. Bookman AA, Williams KS, Shainhouse JZ Effect of a topical diclofenac solution for relieving symptoms of primary osteoarthritis of the knee: A randomized controlled trial. CMAJ. 2004, 171:333-338.
34. Petersen B, Rovati S Diclofenac epolamine (Flector) patch: Evidence for topical activity. Clin Drug Investig. 2009, 29:1-9.
35. Jenoure PJ, Rostan A, Gremion G, et al. Multicenter, double-blind, controlled clinical study of diclofenac Tissugel plaster in patients with epicondylitis. Med Sport (Roma). 1997, 50:285-292.
36. Saillant G Study comparing the efficacy and tolerability of Flector Tissugel to that of a placebo in the treatment of benign ankle sprain. Sports Med. 1998, 72:1-5.
37. Joussellin E Flector Tissugel in the treatment of painful ankle sprain. J Traumatol Sport. 2003, 20. 1S5-1S9.
38. Rowbotham MC, Galer BS, Block JA, Backonja MM Flector Tissugel: Efficacy and safety in the treatment of minor sports injuries. Data from a controlled trial in the United States. J Traumatol Sport. 2003, 20. 1S15-1S20.
39. Carr W, Beks P, Jones C, et al. Efficacy and tolerability of Flector Patch (diclofenac epolamine topical patch) in the treatment of minor soft tissue injury pain. Presented at: American Pain Society 27th Annual Scientific Meeting May 2008, Abstract.
40. Rosenthal M, Bahous I A controlled clinical study on the new topical dosage form of DHEP plasters in patients suffering from localized inflammatory diseases. Drugs Exp Clin Res. 1993, 19:99-105.
41. Jenoure P, Segesser B, Lühti U, Gremion G A trial with diclofenac HEP plaster as topical treatment in minor sport injuries. Drugs Exp Clin Res. 1993, 19:125-131.
42. Yanchick J, Sun S, Pirovano P Safety of diclofenac epolamine topical patch 1.3% evaluated in clinical trials and postmarketing surveillance. Presented at: International Association for the Study of Pain (IASP) 12th World Congress on Pain August 2008.
43. Fuller C, Yanchick J, Zhao W, Magelli M The safety profile of diclofenac epolamine 1.3% topical patch in elderly and non-elderly patients: Pooled analysis of 10 studies. Presented at: The American Geriatrics Society 2009 Annual Scientific Meeting April 2009, Abstract C26 pS121.
44. Polieri T, Saponati G Minor sports injuries in children: A new, safe, topical preparation containing DHEP (diclofenac epolamine). Med Sport. 2000, 53:275-278.
45. Voltaren Gel (diclofenac sodium topical gel) [package insert], Accessed April 30, 2010. http://www.voltarengel.com/pdf/Voltaren-PI-10-19.pdf.
46. Pennsaid (diclofenac sodium topical solution) [package insert]. Accessed April 30, 2010. http://www.pennsaid.com/attachments/PENNSAID_Prescribing_Information.pdf.
47. Qutenza (acapsaicin) [package insert]. Accessed April 30, 2010. http://www.qutenza.com/_docs/qutenza_full_PI_.pdf.